Lactevenor 0.03 mg 35 tablets

Trade name:

Lactevenor

Lactevenor

Compound:

Each tablet contains:

Levonorgestrel 30 mcg

Properties:

The contraceptive effect is carried out by suppressing ovulation and increasing the viscosity of the secretion of the cervix, as a result of which it becomes impermeable to spermatozoa.

In women taking COCs, the cycle becomes more regular, the pain and intensity of menstrual bleeding decrease, resulting in a reduced risk of iron deficiency anemia. In addition, there is evidence that the use of COCs reduces the risk of developing endometrial cancer and ovarian cancer.

Indications:

Oral contraception.

Dosage and administration:

Inside, without chewing, drinking a small amount of liquid. 1 tablet daily, at the same time, starting from the 1st day of menstruation. After the completion of taking the tablets from the first package, the next day, it is continued to be taken from the new package, without pausing between packages.

Contraindications:

Thrombosis (venous and arterial); thromboembolism (including deep vein thrombosis, pulmonary embolism, myocardial infarction).

Migraine with focal neurological symptoms, incl. in history; diabetes mellitus with vascular complications; pancreatitis with severe hypertriglyceridemia, incl. in history; liver failure and severe liver disease (until liver tests return to normal); liver tumors (benign or malignant), incl. in history; identified hormone-dependent malignant neoplasms (including the genital organs or mammary glands) or suspicion of them.

The drug Lactevenor is contraindicated during pregnancy and during breastfeeding.

If pregnancy is detected while taking the drug, it should be immediately canceled.

Precautionary measures:

If any condition, disease, or risk factor listed below is observed, the potential risk and expected benefit of COC use should be carefully weighed, incl. levonorgestrel, on a case-by-case basis, and discuss them with the patient before she decides to start using this drug. In case of worsening, worsening or first manifestation of any of the following conditions or risk factors, the patient should consult with her doctor to decide whether to stop taking this drug.

Side effects:

From the gastrointestinal tract: often – nausea, abdominal pain; infrequently – vomiting, diarrhea.

From the nervous system: often – headache; infrequently – migraine.

Mental disorders: often – depression, mood swings.

On the part of the genital organs and the mammary gland: often – soreness of the mammary glands, engorgement of the mammary glands.

General disorders: often – weight gain; rarely – weight loss.

Storage method:

Store at a temperature not exceeding 30 degrees.

Package:

The cardboard box contains a blister of 35 tablets.